934962-97-7

Upstream product

• 110-89-4 piperidine 
• 110-91-8 morpholine 
• 917237-09-3 11-chloro-dibenzo [b,f][1,4]thiazepine-8-carbonyl chloride 
• 582-22-9 2-phenylpropylamine 
• 2038-57-5 3-Phenylpropan-1-amine 
• 3959-05-5 2-bromobenzylamine 
• 23730-69-0 N-(2-Aminoethyl)-N-ethylaniline 
• 64-04-0 phenethylamine 
• 156-41-2 4-chlorophenylethylamine 
• 109-73-9 N-butylamine 
• 618-36-0 rac-methylbenzylamine 
• 140-75-0 para-fluorobenzylamine 
• 100-46-9 benzylamine 
• 4152-90-3 m-chlorobenzylamine 

Relevant academic research and scientific papers

USE OF CANNABINOID MODULATING COMPOUNDS IN COMBINATION WITH OTHER THERAPEUTIC COMPOUNDS FOR ADJUNCTIVE THERAPY

The present invention relates to pharmaceutical compositions that contain a compound that modulate the activity of a cannabinoid receptor in conjunction with another therapeutic compound and uses of compounds that modulate the activity of a cannabinoid re

IRON CATALYZED CROSS-COUPLING REACTIONS OF IMIDOYL DERIVATIVES

Disclosed is a process for preparing a compound of formula A - N=C(D)(B), from a compound of formula A-N=C(E)(B) and a compound of formula D-M using an iron catalyst, where the process has is represented by Equation (I).

CB-1 MODULATING COMPOUNDS AND THEIR USE

Disclosed herein is a compound of Formula (I). Also disclosed herein is a method of modulating the activity of a cannabinoid receptor using a compound of Formula (I). Furthermore, disclosed herein is a method of treating a disease or condition that would